(S)-2-Nitro-N-(2-(piperidin-1-yl)-4-(trifluoromethoxy)benzyl)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-amine

ID: ALA1822838

Chembl Id: CHEMBL1822838

PubChem CID: 53465671

Max Phase: Preclinical

Molecular Formula: C19H22F3N5O4

Molecular Weight: 441.41

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=[N+]([O-])c1cn2c(n1)OC[C@@H](NCc1ccc(OC(F)(F)F)cc1N1CCCCC1)C2

Standard InChI:  InChI=1S/C19H22F3N5O4/c20-19(21,22)31-15-5-4-13(16(8-15)25-6-2-1-3-7-25)9-23-14-10-26-11-17(27(28)29)24-18(26)30-12-14/h4-5,8,11,14,23H,1-3,6-7,9-10,12H2/t14-/m0/s1

Standard InChI Key:  CPRPZSVRTSDWEU-AWEZNQCLSA-N

Associated Targets(non-human)

Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ddn Putative uncharacterized protein (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 441.41Molecular Weight (Monoisotopic): 441.1624AlogP: 3.23#Rotatable Bonds: 6
Polar Surface Area: 94.69Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.79CX LogP: 4.78CX LogD: 4.24
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.54Np Likeness Score: -1.07

References

1. Cherian J, Choi I, Nayyar A, Manjunatha UH, Mukherjee T, Lee YS, Boshoff HI, Singh R, Ha YH, Goodwin M, Lakshminarayana SB, Niyomrattanakit P, Jiricek J, Ravindran S, Dick T, Keller TH, Dartois V, Barry CE..  (2011)  Structure-activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((s)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-amino PA-824).,  54  (16): [PMID:21755942] [10.1021/jm1010644]

Source